Sept.28.2009.CGPA. Canada is hosting the 12th Annual International Generic Pharmaceutical Alliance (IGPA) Conference in Montréal from September 30 through October 2, 2009, the first time the event has been held in Canada.
Originally founded in 1997, the IGPA works to represent the generic pharmaceutical industry on the world stage and to ensure governments, employers and patients have access to affordable medicines. This year’s conference will be held at the new Westin Hotel in Montréal’s historic Old Port area.
“The IGPA Conference has become the premier event for the international generic pharmaceutical industry. As an international leader in generic pharmaceutical research, development and manufacturing, Canada is pleased to welcome representatives of our industry from around the Globe,” said Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA).
The annual IGPA Conference offers an excellent opportunity to gain insight into the most recent commercial, legal and regulatory developments related to the global generic pharmaceutical industry. The conference attracts senior executives from the world’s leading generic pharmaceutical manufacturers from around the world, including the United States, Europe, India, Japan, Brazil, Jordan, Taiwan and South Africa.
Key agenda items for this year’s conference include:
- Financial Outlook for Generic Industry/Companies in the Economic Downturn
- Subsequent Entry Biologics/Biosimilars
- Key Developments in Intellectual Property Affecting Access to Generic Medicines
The premier event for the 2009 Conference will be the CEO Panel, “Leadership in Tough Times” which promises to be a lively session with executives of the world’s leading generic firms.
For more information and a detailed agenda visit the conference website at www.igpamontreal2009.com.